Canola-Mediterranean Diet Study in T2DM

NCT02245399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2018-09-18

No results posted yet for this study

Summary

The purpose of the study is to assess whether a Mediterranean-type weight-loss diet, enriched with canola oil, high in plant protein, and low in carbohydrates will produce blood sugar control, reduce coronary heart disease (CHD) risk factors and maximize weight loss, better than conventional higher carbohydrate diets in overweight diabetic patients.

Conditions

Interventions

BEHAVIORAL

A canola oil enriched mediterranean diet

The diet will be provided at 60% of calories estimated for stable body weight to encourage weight loss. A high protein canola oil-enriched test bread will be provided as a supplement.

BEHAVIORAL

A high wheat fiber diet

The diet will be provided at 60% of calories estimated for stable body weight to encourage weight loss. A whole wheat control bread will be provided as a supplement to participants

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER
  • Laval University

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • Canola Council of Canada

    collaborator OTHER
  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • David J Jenkins, MD · St. Michael's Hospital / University of Toronto

  • Cyril Kendall, PhD · University of Toronto

  • Vladimir Vuksan, PhD · Unity Health Toronto

  • Peter Jones, PhD · University of Manitoba

  • Benoit Lamarche, PhD · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-12-14
Completion
2017-03-13

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02245399 on ClinicalTrials.gov